Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Hyodo

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Pharmaceutics|July 21, 2022
Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibodyAlaa M Khalifa, Takashi Nakamura, Yusuke Sato, et al.
Molecular Microbiology|September 11, 2007
A cyclic-di-GMP receptor required for bacterial exopolysaccharide productionVincent T Lee, Jody M Matewish, Jennifer L Kessler, et al.
Biological & Pharmaceutical Bulletin|November 5, 2014
Construction of an aptamer modified liposomal system targeted to tumor endothelial cellsMst Naznin Ara, Takashi Matsuda, Mamoru Hyodo, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formationDavid K R Karaolis, Mohammed H Rashid, Rajanna Chythanya, et al.
Vaccine|May 2, 2009
c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infectionDong-Liang Hu, Kouji Narita, Mamoru Hyodo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2013
RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA systemYu Sakurai, Hiroto Hatakeyama, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2022
Combined nano cancer immunotherapy based on immune status in a tumor microenvironmentTakashi Nakamura, Kyoko Kawakami, Momoka Nomura, et al.
FEMS Microbiology Letters|February 20, 2010
Effect of cyclic bis(3'-5')diguanylic acid and its analogs on bacterial biofilm formationYuka Ishihara, Mamoru Hyodo, Yoshihiro Hayakawa, et al.
Nature Communications|March 28, 2019
Rapid mantle flow with power-law creep explains deformation after the 2011 Tohoku mega-quakeRyoichiro Agata, Sylvain D Barbot, Kohei Fujita, et al.
Biomaterials|May 31, 2014
An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cellsMst Naznin Ara, Takashi Matsuda, Mamoru Hyodo, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Pharmaceutics|July 21, 2022
Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibodyAlaa M Khalifa, Takashi Nakamura, Yusuke Sato, et al.
Molecular Microbiology|September 11, 2007
A cyclic-di-GMP receptor required for bacterial exopolysaccharide productionVincent T Lee, Jody M Matewish, Jennifer L Kessler, et al.
Biological & Pharmaceutical Bulletin|November 5, 2014
Construction of an aptamer modified liposomal system targeted to tumor endothelial cellsMst Naznin Ara, Takashi Matsuda, Mamoru Hyodo, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formationDavid K R Karaolis, Mohammed H Rashid, Rajanna Chythanya, et al.
Vaccine|May 2, 2009
c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infectionDong-Liang Hu, Kouji Narita, Mamoru Hyodo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2013
RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA systemYu Sakurai, Hiroto Hatakeyama, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2022
Combined nano cancer immunotherapy based on immune status in a tumor microenvironmentTakashi Nakamura, Kyoko Kawakami, Momoka Nomura, et al.
FEMS Microbiology Letters|February 20, 2010
Effect of cyclic bis(3'-5')diguanylic acid and its analogs on bacterial biofilm formationYuka Ishihara, Mamoru Hyodo, Yoshihiro Hayakawa, et al.
Nature Communications|March 28, 2019
Rapid mantle flow with power-law creep explains deformation after the 2011 Tohoku mega-quakeRyoichiro Agata, Sylvain D Barbot, Kohei Fujita, et al.
Biomaterials|May 31, 2014
An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cellsMst Naznin Ara, Takashi Matsuda, Mamoru Hyodo, et al.
Pageof 8